ENVUE MEDICAL INC (FEED)
NASDAQHealth CareMedical - SpecialtiesSnapshot 2026-11-04
$0.35+0.29%
Close 2026-10-12 · 1-day change
NASDAQHealth CareMedical - SpecialtiesSnapshot 2026-11-04
QuarterlyIQ Insights · FEED
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Exhibit 99.1 ENvue Medical, Inc. Announces 1-for-12 Reverse Stock Split TYLER, Texas, August 28, 2026 (GLOBE NEWSWIRE), ENvue Medical, Inc. (NASDAQ: FEED) (“ENvue” or the “Company”), a commercial-sta…
Stated in a supplied disclosure. Management reported: “Exhibit 99.1 ENvue Medical, Inc. Announces 1-for-12 Reverse Stock Split TYLER, Texas, August 28, 2026 (GLOBE NEWSWIRE), ENvue Medical, Inc. (NASDAQ: FEED) (“ENvue” or the “Company”), a commercial-stage medical technology company, today announced that a reverse stock split of the Company’s issued and outstanding common stock, par value $0.001 per share (the “Common Stock”) at a ratio of 1-for-12 is expected to become effective on September 1, 2026.”
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Health Care names rated neutral grew net income 51% of the time over the next year (vs 41% for the rest of the cohort, n=13498).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Future platform expansion may include pediatric and vascular access applications.
Stated in a supplied disclosure. Management reported: “About ENvue Medical, Inc. ENvue Medical, Inc. (NASDAQ: FEED) is a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings.” “Future platform expansion may include pediatric and vascular access applications.”
|| ● | Acoustic-based therapeutic technologies, including PainShield® and UroShield®, with research and development in Tel Aviv, Israel, and manufacturing operations in the United States, which utili…
Stated in a supplied disclosure. Management reported: “|| ● | Acoustic-based therapeutic technologies, including PainShield® and UroShield®, with research and development in Tel Aviv, Israel, and manufacturing operations in the United States, which utilize proprietary low-intensity surface acoustic wave (SAW) technology.” “These devices are intended for use in home or care settings and are designed to treat pain, reduce bacterial colonization, and disrupt biofilms.”
Resolve Nasdaq listing issues related to the stock price to maintain listing status and investor confidence.
Obtain and utilize a committed equity facility to strengthen the Company's capital position and support operations.
Over the trailing year it converted 0.87x of net income into operating cash flow.
Not enough signal yet.
Not enough signal to read sensitivity to the broad stock market, the US dollar, long-term interest rates, real (inflation-adjusted) rates, Fed net liquidity (low R² over the window).
35 material management or governance events in the past 24 months, led by capital-allocation actions. Historically, Health Care names rated volatile grew net income 45% of the time over the next year (vs 45% for the rest of the cohort, n=10076).
Not investment advice. As of 2026-11-04.